GB1400643A - Dermatological compositions - Google Patents

Dermatological compositions

Info

Publication number
GB1400643A
GB1400643A GB1608073A GB1608073A GB1400643A GB 1400643 A GB1400643 A GB 1400643A GB 1608073 A GB1608073 A GB 1608073A GB 1608073 A GB1608073 A GB 1608073A GB 1400643 A GB1400643 A GB 1400643A
Authority
GB
United Kingdom
Prior art keywords
hydroxy
substituted alkyl
carbon atoms
alkyl group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1608073A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of GB1400643A publication Critical patent/GB1400643A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB1608073A 1972-04-05 1973-04-04 Dermatological compositions Expired GB1400643A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24140472A 1972-04-05 1972-04-05

Publications (1)

Publication Number Publication Date
GB1400643A true GB1400643A (en) 1975-07-23

Family

ID=22910564

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1608073A Expired GB1400643A (en) 1972-04-05 1973-04-04 Dermatological compositions

Country Status (15)

Country Link
JP (1) JPS5331222B2 (de)
AT (1) AT352283B (de)
BE (1) BE797763A (de)
CH (1) CH593690A5 (de)
DE (2) DE2316597C3 (de)
DK (1) DK138929B (de)
FI (1) FI52427C (de)
FR (1) FR2182935B1 (de)
GB (1) GB1400643A (de)
IE (1) IE37447B1 (de)
NL (1) NL172402C (de)
NO (1) NO141740C (de)
PH (1) PH15138A (de)
SE (1) SE419940B (de)
ZA (1) ZA732269B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2166954A (en) * 1984-11-16 1986-05-21 Oreal Heat-slimming composition
WO2001021575A1 (en) * 1999-09-17 2001-03-29 Women's And Children's Hospital Adelaide Anti-inflammatory nitro- and thia- fatty acids
EP0989846B1 (de) * 1997-09-30 2004-11-24 E-L Management Corp. Nichtirritierende kosmetische und pharmazeutische zusammensetzungen

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383667A1 (fr) * 1977-03-16 1978-10-13 Desjonqueres Stephane Medicament contre l'acne
JPS5668603A (en) * 1979-11-09 1981-06-09 Nippon Saafuakutanto Kogyo Kk Cosmetic
JPS60116218U (ja) * 1984-01-17 1985-08-06 東北金属工業株式会社 チヨ−クコイル
GB8514975D0 (en) * 1985-06-13 1985-07-17 Sempernova Plc Compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
EP0444778A1 (de) * 1990-02-14 1991-09-04 Alcon Laboratories, Inc. Verwendung von Alkylsacchariden zur Förderung der Penetration von Arzneistoffen
ZA912228B (en) * 1990-03-30 1991-12-24 Alza Corp Compositions comprising cytotoxic agent and permeation enhancers
JPH0817647A (ja) * 1994-06-24 1996-01-19 I Kiyuu For:Kk トランス
RS62825B1 (sr) 2017-07-20 2022-02-28 Thomas Leibbrand Tirotricin za upotrebu u lečenju ili profilaksi telesnih mirisa i preparati za to

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE644613A (de) * 1963-12-09 1964-07-01
GB1081577A (en) * 1964-06-29 1967-08-31 Procter & Gamble Scopolamine esters and acid addition salts thereof useful as anti-perspirant agents
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2166954A (en) * 1984-11-16 1986-05-21 Oreal Heat-slimming composition
EP0989846B1 (de) * 1997-09-30 2004-11-24 E-L Management Corp. Nichtirritierende kosmetische und pharmazeutische zusammensetzungen
WO2001021575A1 (en) * 1999-09-17 2001-03-29 Women's And Children's Hospital Adelaide Anti-inflammatory nitro- and thia- fatty acids

Also Published As

Publication number Publication date
CH593690A5 (de) 1977-12-15
ATA295673A (de) 1979-02-15
JPS4925113A (de) 1974-03-06
NL7304699A (de) 1973-10-09
JPS5331222B2 (de) 1978-09-01
FI52427B (de) 1977-05-31
DK138929B (da) 1978-11-20
PH15138A (en) 1982-08-24
DE2366081A1 (de) 1977-10-06
IE37447B1 (en) 1977-07-20
DE2316597B2 (de) 1978-03-16
DE2366081C2 (de) 1985-11-07
AT352283B (de) 1979-09-10
FI52427C (fi) 1977-09-12
NL172402C (nl) 1983-09-01
DK138929C (de) 1979-05-07
FR2182935B1 (de) 1976-12-31
ZA732269B (en) 1974-01-30
NL172402B (nl) 1983-04-05
DE2316597C3 (de) 1978-11-02
NO141740C (no) 1980-05-07
SE419940B (sv) 1981-09-07
BE797763A (fr) 1973-10-04
IE37447L (en) 1973-10-05
FR2182935A1 (de) 1973-12-14
NO141740B (no) 1980-01-28
DE2316597A1 (de) 1973-10-18

Similar Documents

Publication Publication Date Title
GB1400643A (en) Dermatological compositions
IL112081A (en) Tetrahydrofuran derivatives, their preparation and antifungal pharmaceutical compositions containing them
AU585495B2 (en) Pharmaceutical composition for the treatment of acute myocardial ischemia
IE780061L (en) Fungicidal compositions
IE851615L (en) Topical composition
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
US4668664A (en) Bi- or tri-enic fatty esters of erythromycin A; pharmaceutical and cosmetic compositions containing them
ES8306164A1 (es) Un procedimiento de preparacion de derivados de 4-pregneno .
GB1536515A (en) Compositions containing silicon derivatives
IE43693L (en) Androstane derivatives
IT1196041B (it) Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
DE3273108D1 (en) 17-alpha-alkyl-17-beta-hydroxy-1-alpha-methyl-4-androsten-3-ones, process for their preparation and pharmaceutical compositions containing them
GB1243322A (en) 2,2-dihalogeno-ethyl-benzene derivatives, processes for preparing them, and compositions containing them
GB1487543A (en) Dermatological composition
JPS55133370A (en) Pentofuranosylanthracycline*its manufacture and antitumor containing it
GB1487545A (en) Dermatological composition
US5004734A (en) Diaromatic esters of macrolidic and lincosamidic antibiotics and pharmaceutical and cosmetic compositions containing them
HUT34995A (en) Process for producing 7-alpha-substituted-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone derivatives and pharmaceutical compositions containing them as active agents
ES468293A1 (es) Procedimiento para preparar derivados de a-nor-androsta-3 (5),16-dien-2-ona.
GB2001974A (en) Vincinic acid derivatives and process for the preparation thereof
US5004733A (en) Esters of the etretinic type or related to macrolidic and lincosamidic antibiotics and pharmaceutical and cosmetic compositions containing said esters
EP0414913A4 (en) P-aminophenol derivative and production and application thereof
GB1525294A (en) Compositions containing substituted bis-chromonyl compounds
BE876713A (fr) Medicament constitue par un derive de cyclopentyl-aldehyde et composition le renfermant

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19930403